RxDoctor Payments Data

Corinna Zygourakis, MD

Neurological Surgery · Palo Alto, CANPI 1235456476

Payments from drug & device makers

$97,040in general payments, 2019–2025

Across 95 payments — averaging $1021.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$69K
  • Globus Medical$9K
  • 7d Surgical Inc.$7K
  • 7d Surgical ULC$5K
  • Amgen$3K
  • Zimmer Biomet$2K
  • plus $2K from 4 others
$264in research payments, 2019–2025

Across 2 payments — averaging $131.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$264

What the payments were for

  • Consulting fees$37,72580%
  • Travel & lodging$3,4427%
  • Food & beverage$5,87312%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker45$68,829
Globus Medical(2 entities)21$8,990
7d Surgical Inc.3$7,378
7d Surgical ULC2$5,089
Amgen3$3,345
Zimmer Biomet7$1,736
Medtronic(2 entities)10$1,189
Johnson & Johnson2$209
Alphatec Spine, Inc1$143
Si-bone, Inc.1$133

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,040 in reported general payments places this provider in the 80th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California

Medicare billing

Part B allowed, 2024
$116,790
Medicare patients
150
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib12$460

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →